Brief: Collegium Pharmaceutical Announces Redemption Of Outstanding 2.625% Convertible Senior Notes Due 2026
11/04/2024 15:36
April 11 (Reuters) - Collegium Pharmaceutical Inc
COLL.O :
* COLLEGIUM PHARMACEUTICAL, INC. ANNOUNCES REDEMPTION OF
OUTSTANDING 2.625% CONVERTIBLE SENIOR NOTES DUE 2026
* COLLEGIUM PHARMACEUTICAL INC: HAS CALLED ALL $26.35
MILLION
AGGREGATE PRINCIPAL AMOUNT OF ITS OUTSTANDING 2.625% CONVERTIBLE
SENIOR NOTES DUE 2026
Source text for Eikon: ID:nGNXYP0zn
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%